Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Drug Therapy"" wg kryterium: Temat


Tytuł :
Post PCI severe gastrointestinal bleeding in the setting of idiopathic thrombocytopenic purpura: a treatment dilemma.
Autorzy :
Ghafoor H; Department of Cardiology, Saint Vincent Hospital, Worcester, Massachusetts, USA .
Sharma NK; Department of Cardiology, Saint Vincent Hospital, Worcester, Massachusetts, USA.
Alampoondi Venkataramanan SV; Department of Internal Medicine, Saint Vincent Hospital, Worcester, Massachusetts, USA.
Hadley M; Department of Cardiology, Saint Vincent Hospital, Worcester, Massachusetts, USA.
Pokaż więcej
Źródło :
BMJ case reports [BMJ Case Rep] 2021 Jun 23; Vol. 14 (6). Date of Electronic Publication: 2021 Jun 23.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Atrial Fibrillation*/complications
Atrial Fibrillation*/drug therapy
Percutaneous Coronary Intervention*
Purpura, Thrombocytopenic, Idiopathic*/complications
Purpura, Thrombocytopenic, Idiopathic*/drug therapy
Anticoagulants/adverse effects ; Drug Therapy, Combination ; Gastrointestinal Hemorrhage/drug therapy ; Gastrointestinal Hemorrhage/therapy ; Humans ; Platelet Aggregation Inhibitors/adverse effects
Czasopismo naukowe
Tytuł :
Effect of aprepitant on kynurenine to tryptophan ratio in cART treated and cART naïve adults living with HIV.
Autorzy :
Spitsin S; Children's Hospital of Philadelphia Research Institute.
Pappa V; Children's Hospital of Philadelphia Research Institute.
Kinder A; Children's Hospital of Philadelphia Research Institute.
Evans DL; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Rappaport J; Tulane National Primate Research Center, Covington, LA, USA.
Douglas SD; Children's Hospital of Philadelphia Research Institute.; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2021 Jun 11; Vol. 100 (23), pp. e25313.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Aprepitant*/administration & dosage
Aprepitant*/adverse effects
HIV Infections*/drug therapy
HIV Infections*/immunology
HIV Infections*/psychology
HIV Infections*/virology
Mood Disorders*/drug therapy
Mood Disorders*/etiology
Ritonavir*/administration & dosage
Ritonavir*/adverse effects
Neuroimmunomodulation/*drug effects
Tryptophan/*metabolism
Adult ; Anti-HIV Agents/administration & dosage ; Anti-HIV Agents/adverse effects ; CD4 Lymphocyte Count/methods ; Double-Blind Method ; Drug Therapy, Combination/adverse effects ; Drug Therapy, Combination/methods ; Female ; Humans ; Kynurenine/analysis ; Male ; Neurokinin-1 Receptor Antagonists/administration & dosage ; Neurokinin-1 Receptor Antagonists/adverse effects ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Factors influencing the failure of interferon-free therapy for chronic hepatitis C: Data from the Polish EpiTer-2 cohort study.
Autorzy :
Janczewska E; Department of Basic Medical Sciences, The School of Health Sciences in Bytom, Medical University of Silesia, Bytom 41-902, Poland. .
Kołek MF; Department of Animal Physiology, Faculty of Biology, University of Warsaw, Warszawa 02-096, Poland.
Lorenc B; Pomeranian Center of Infectious Diseases, Medical University Gdańsk, Gdańsk 80-214, Poland.
Klapaczyński J; Department of Internal Medicine and Hepatology, Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warszawa 02-507, Poland.
Tudrujek-Zdunek M; Department of Infectious Diseases, Medical University of Lublin, Lublin 20-081, Poland.
Sitko M; Department of Infectious and Tropical Diseases, Jagiellonian University, Kraków 30-688, Poland.
Mazur W; Clinical Department of Infectious Diseases, Medical University of Silesia in Katowice, Chorzów 41-500, Poland.
Zarębska-Michaluk D; Department of Infectious Diseases, Jan Kochanowski University Kielce, Kielce 25-369, Poland.
Buczyńska I; Department of Infectious Diseases and Hepatology, Medical University Wrocław, Wrocław 51-149, Poland.
Dybowska D; Department of Infectious Diseases and Hepatology, Ludwik Rydygier Collegium Medicum in Bydgoszcz Faculty of Medicine Nicolaus Copernicus University in Toruń, Bydgoszcz 85-030, Poland.
Czauż-Andrzejuk A; Department of Infectious Diseases and Hepatology, Medical University of Białystok, Białystok 15-540, Poland.
Berak H; One-Day Department, Hospital for Infectious Diseases in Warsaw, Warszawa 01-201, Poland.
Krygier R; Outpatient Clinic, State University of Applied Sciences in Konin, Konin 62-510, Poland.
Jaroszewicz J; Department of Infectious Diseases and Hepatology, Medical University of Silesia in Katowice, Bytom 41-902, Poland.
Citko J; Department of Medical Practice of Infections, Regional Hospital, Olsztyn 10-561, Poland.
Piekarska A; Department of Infectious Diseases and Hepatology, Medical University of Łódź, Łódź 90-419, Poland.
Dobracka B; MedicalSpec Center, Wrocław 53-428, Poland.
Socha Ł; Department of Infectious Diseases, Hepatology and Liver Transplantation, Pomeranian Medical University, Szczecin 71-455, Poland.
Deroń Z; Ward of Infectious Diseases and Hepatology, Biegański Regional Specialist Hospital, Łódź 91-347, Poland.
Laurans Ł; Department of Infectious Diseases, Hepatology and Liver Transplantation, Pomeranian Medical University, Szczecin 71-455, Poland.
Białkowska-Warzecha J; Department of Infectious and Liver Diseases, Medical University of Łódź, Łódź 91-347, Poland.
Tronina O; Department of Transplantation Medicine, Nephrology, and Internal Diseases, Medical University of Warsaw, Warszawa 02-091, Poland.
Adamek B; Department of Basic Medical Sciences, The School of Health Sciences in Bytom, Medical University of Silesia, Bytom 41-902, Poland.
Tomasiewicz K; Department of Infectious Diseases, Medical University of Lublin, Lublin 20-081, Poland.
Simon K; Department of Infectious Diseases and Hepatology, Medical University Wrocław, Wrocław 51-149, Poland.
Pawłowska M; Department of Paediatric Infectious Diseases and Hepatology, Faculty of Medicine, Collegium Medicum Bydgoszcz, Nicolaus Copernicus University Toruń, Bydgoszcz 85-030, Poland.
Halota W; Department of Infectious Diseases and Hepatology, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Faculty of Medicine, Nicolaus Copernicus University in Toruń, Bydgoszcz 85-030, Poland.
Flisiak R; Department of Infectious Diseases and Hepatology, Medical University of Białystok, Białystok 15-540, Poland.
Pokaż więcej
Źródło :
World journal of gastroenterology [World J Gastroenterol] 2021 May 14; Vol. 27 (18), pp. 2177-2192.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
End Stage Liver Disease*/drug therapy
Hepatitis C, Chronic*/drug therapy
Liver Neoplasms*/drug therapy
Antiviral Agents/adverse effects ; Child ; Cohort Studies ; Drug Therapy, Combination ; Genotype ; Hepacivirus/genetics ; Humans ; Liver Cirrhosis/drug therapy ; Male ; Middle Aged ; Poland ; Severity of Illness Index ; Sustained Virologic Response ; Treatment Outcome
Czasopismo naukowe
Tytuł :
The predictors of sustained virological response with sofosbuvir and ribavirin in patients with chronic hepatitis C genotype 2.
Autorzy :
Han SY; Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea.; Medical Research Institute, Pusan National University Hospital, Busan, Korea.
Woo HY; Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea.; Medical Research Institute, Pusan National University Hospital, Busan, Korea.
Heo J; Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea.; Medical Research Institute, Pusan National University Hospital, Busan, Korea.
Park SG; Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea.; Medical Research Institute, Pusan National University Hospital, Busan, Korea.
Pyeon SI; Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea.; Medical Research Institute, Pusan National University Hospital, Busan, Korea.
Park YJ; Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea.; Medical Research Institute, Pusan National University Hospital, Busan, Korea.
Kim DU; Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea.; Medical Research Institute, Pusan National University Hospital, Busan, Korea.
Kim GH; Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea.; Medical Research Institute, Pusan National University Hospital, Busan, Korea.
Kim HH; Medical Research Institute, Pusan National University Hospital, Busan, Korea.; Department of Laboratory Medicine, Pusan National University School of Medicine Busan, Korea.
Song GA; Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea.; Medical Research Institute, Pusan National University Hospital, Busan, Korea.
Cho M; Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea.; Medical Research Institute, Pusan National University Hospital, Busan, Korea.
Pokaż więcej
Źródło :
The Korean journal of internal medicine [Korean J Intern Med] 2021 May; Vol. 36 (3), pp. 544-556. Date of Electronic Publication: 2019 Mar 19.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Carcinoma, Hepatocellular*/drug therapy
Hepatitis C, Chronic*/diagnosis
Hepatitis C, Chronic*/drug therapy
Liver Neoplasms*/drug therapy
Antiviral Agents/adverse effects ; Drug Therapy, Combination ; Genotype ; Hepacivirus/genetics ; Humans ; Liver Cirrhosis/diagnosis ; Liver Cirrhosis/drug therapy ; Neoplasm Recurrence, Local ; Ribavirin/adverse effects ; Sofosbuvir/adverse effects ; Treatment Outcome
Czasopismo naukowe
Tytuł :
[A multicenter randomized controlled study of bismuth-containing quadruple therapy followed by Jing-Hua-Wei-Kang in the treatment of patients newly diagnosed with Helicobacter pylori infection and dyspepsia].
Autorzy :
Ma PP; Department of Gastroenterology, the First Affiliated Hospital of Zhejiang Chinese Medical University, Key Laboratory for Pathophysiological Research on Digestive System Diseases of Zhejiang Province, Hangzhou 310060, China.
Meng LN; Department of Gastroenterology, the First Affiliated Hospital of Zhejiang Chinese Medical University, Key Laboratory for Pathophysiological Research on Digestive System Diseases of Zhejiang Province, Hangzhou 310060, China.
Wang MT; Department of Gastroenterology, Jilin People's Hospital, Jilin 132012, China.
Jin HF; Department of Gastroenterology, the First Affiliated Hospital of Zhejiang Chinese Medical University, Key Laboratory for Pathophysiological Research on Digestive System Diseases of Zhejiang Province, Hangzhou 310060, China.
Fan YH; Department of Gastroenterology, the First Affiliated Hospital of Zhejiang Chinese Medical University, Key Laboratory for Pathophysiological Research on Digestive System Diseases of Zhejiang Province, Hangzhou 310060, China.
Zha AS; Department of Gastroenterology, the First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230031, China.
Huo XH; Department of Gastroenterology, the First Hospital of Hebei Medical University, Shijiazhuang 050023, China.
Chen DF; Department of Gastroenterology, the Chinese People's Liberation Army Medical Center, Chongqing 400042, China.
Cao ZQ; Department of Gastroenterology, the Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250011, China.
Tang XF; Department of Gastroenterology, Heilongjiang Provincial Hospital, Harbin 150030, China.
Yang P; Department of Gastroenterology, Xiangyin People's Hospital, Xiangyin 410500, China.
Shi ZH; Department of Gastroenterology, Wuhan No.1 Hospital, Wuhan 430033, China.
Li TW; Department of Gastroenterology, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan 430006, China.
Meng J; Department of Gastroenterology, the Affiliated Hospital of Hebei University, Baoding 071030, China.
Gan C; the First Department of Gastroenterology, the Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang 330006, China.
Chen GX; Department of Gastroenterology, Xuzhou No.1 People's Hospital, Xuzhou 221002, China.
Sha WH; Department of Gastroenterology, Guangdong Provincial People's Hospital, Guangzhou 510080, China.
Du Q; Department of Gastroenterology, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China.
Li Y; Department of Gastroenterology, Shengjing Hospital of China Medical University, Shenyang 110004, China.
Lyu B; Department of Gastroenterology, the First Affiliated Hospital of Zhejiang Chinese Medical University, Key Laboratory for Pathophysiological Research on Digestive System Diseases of Zhejiang Province, Hangzhou 310060, China.
Pokaż więcej
Źródło :
Zhonghua yi xue za zhi [Zhonghua Yi Xue Za Zhi] 2021 Jul 13; Vol. 101 (26), pp. 2060-2065.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms :
Dyspepsia*/drug therapy
Helicobacter Infections*/drug therapy
Helicobacter pylori*
Amoxicillin/therapeutic use ; Anti-Bacterial Agents/therapeutic use ; Bismuth/therapeutic use ; China ; Drug Therapy, Combination ; Female ; Humans ; Male ; Middle Aged ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Campylobacter fetus bacteremia and meningitis in an acute lymphoblastic leukemia patient undergoing maintenance therapy: a case report.
Autorzy :
Nakatani R; Department of Internal Medicine, St. Luke's International Hospital, 9-1, Akashi-cho, Chuo-ku, Tokyo, Japan. .
Shimizu K; Department of Hematology, St. Luke's International Hospital, Tokyo, Japan.
Matsuo T; Department of Infectious Diseases, St. Luke's International Hospital, Tokyo, Japan.
Koyamada R; Department of Hematology, St. Luke's International Hospital, Tokyo, Japan.
Mori N; Department of Infectious Diseases, St. Luke's International Hospital, Tokyo, Japan.
Yamashita T; Department of Hematology, St. Luke's International Hospital, Tokyo, Japan.
Mori S; Department of Hematology, St. Luke's International Hospital, Tokyo, Japan.
Pokaż więcej
Źródło :
BMC infectious diseases [BMC Infect Dis] 2021 Jul 13; Vol. 21 (1), pp. 680. Date of Electronic Publication: 2021 Jul 13.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Campylobacter Infections*/blood
Campylobacter Infections*/cerebrospinal fluid
Campylobacter Infections*/diagnosis
Campylobacter Infections*/drug therapy
Foodborne Diseases*/complications
Foodborne Diseases*/diagnosis
Foodborne Diseases*/drug therapy
Foodborne Diseases*/microbiology
Meningitis, Bacterial*/diagnosis
Meningitis, Bacterial*/drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/complications
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Campylobacter fetus/*isolation & purification
Ceftriaxone/*administration & dosage
Meropenem/*administration & dosage
Adult ; Anti-Bacterial Agents/administration & dosage ; Diagnosis, Differential ; Drug Therapy/methods ; Drug-Related Side Effects and Adverse Reactions/diagnosis ; Female ; Humans ; Treatment Outcome
Czasopismo naukowe
Tytuł :
DrugComb update: a more comprehensive drug sensitivity data repository and analysis portal.
Autorzy :
Zheng S; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki FI-00290, Finland.
Aldahdooh J; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki FI-00290, Finland.
Shadbahr T; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki FI-00290, Finland.
Wang Y; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki FI-00290, Finland.
Aldahdooh D; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki FI-00290, Finland.
Bao J; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki FI-00290, Finland.; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki FI-00290, Finland.
Wang W; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki FI-00290, Finland.
Tang J; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki FI-00290, Finland.
Pokaż więcej
Źródło :
Nucleic acids research [Nucleic Acids Res] 2021 Jul 02; Vol. 49 (W1), pp. W174-W184.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Algorithms*
Databases, Factual*
Drug Evaluation, Preclinical*
Drug Therapy, Combination*
Internet*
COVID-19/drug therapy ; Data Visualization ; Datasets as Topic ; Drug Synergism ; Hemorrhagic Fever, Ebola/drug therapy ; Humans ; Machine Learning ; Malaria/drug therapy ; Neoplasms/drug therapy
Czasopismo naukowe
Tytuł :
Results of Register in Patients with Acute Coronary Syndrome and Atrial Fibrillation Receiving Rivaroxaban.
Autorzy :
Baturina OА; I.M. Sechenov First Moscow State Medical University (Sechenov University),Moscow.
Andreev DA; I.M. Sechenov First Moscow State Medical University (Sechenov University),Moscow.
Sychev DIA; Russian Medical Academy of Continuous Professional Education, Ministry of Health of the Russian Federation, Moscow.
Mesitskaya DF; I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow.
Andranovich SV; I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow.
Babakova NA; I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow.
Suvorov AY; I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow.
Pokaż więcej
Źródło :
Kardiologiia [Kardiologiia] 2021 Jul 01; Vol. 61 (6), pp. 52-58. Date of Electronic Publication: 2021 Jul 01.
Typ publikacji :
Journal Article
MeSH Terms :
Acute Coronary Syndrome*/drug therapy
Atrial Fibrillation*/complications
Atrial Fibrillation*/drug therapy
Anticoagulants/therapeutic use ; Drug Therapy, Combination ; Factor Xa Inhibitors/adverse effects ; Humans ; Platelet Aggregation Inhibitors/therapeutic use ; Rivaroxaban/adverse effects
Czasopismo naukowe
Tytuł :
Efficacy and safety of tamsulosin vs its combination with mirabegron in the management of lower urinary tract non-neurogenic overactive bladder symptoms (OABS) because of Benign Prostatic Enlargement (BPE)-An open label randomised controlled clinical study.
Autorzy :
Singh I; Department of Surgery (Urology), University College of Medical Sciences (University of Delhi) & GTB Hospital, Delhi, India.
Behera DP; Department of Surgery, University College of Medical Sciences (University of Delhi) & GTB Hospital, Delhi, India.
T K A; Department of Surgery, University College of Medical Sciences (University of Delhi) & GTB Hospital, Delhi, India.
Gupta S; Department of Surgery, University College of Medical Sciences (University of Delhi) & GTB Hospital, Delhi, India.
Pokaż więcej
Źródło :
International journal of clinical practice [Int J Clin Pract] 2021 Jul; Vol. 75 (7), pp. e14184. Date of Electronic Publication: 2021 Apr 19.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Prostatic Hyperplasia*/complications
Prostatic Hyperplasia*/drug therapy
Urinary Bladder, Overactive*/drug therapy
Acetanilides ; Drug Therapy, Combination ; Humans ; Male ; Quality of Life ; Tamsulosin/therapeutic use ; Thiazoles ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Japanese Man with HCV Genotype 4 Infection and Cirrhosis Who Was Successfully Treated by the Combination of Glecaprevir and Pibrentasvir.
Autorzy :
Totsuka M; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Japan.
Honda M; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Japan.
Kanda T; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Japan.
Ishii T; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Japan.
Matsumoto N; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Japan.
Yamana Y; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Japan.
Kaneko T; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Japan.
Mizutani T; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Japan.
Takahashi H; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Japan.
Kumagawa M; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Japan.
Sasaki R; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Japan.
Masuzaki R; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Japan.
Kanezawa S; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Japan.
Nirei K; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Japan.
Yamagami H; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Japan.
Matsuoka S; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Japan.
Ohnishi H; Division of Virology, Department of Infection and Immunity, Jichi Medical University School of Medicine, Japan.
Okamoto H; Division of Virology, Department of Infection and Immunity, Jichi Medical University School of Medicine, Japan.
Moriyama M; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Japan.
Pokaż więcej
Źródło :
Internal medicine (Tokyo, Japan) [Intern Med] 2021 Jul 01; Vol. 60 (13), pp. 2061-2066. Date of Electronic Publication: 2021 Feb 01.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Hepacivirus*/genetics
Hepatitis C, Chronic*/complications
Hepatitis C, Chronic*/drug therapy
Adult ; Aged ; Antiviral Agents/therapeutic use ; Benzimidazoles ; Drug Combinations ; Drug Therapy, Combination ; Genotype ; Humans ; Japan ; Liver Cirrhosis/drug therapy ; Male ; Pyrrolidines ; Quinoxalines ; Sulfonamides
Czasopismo naukowe
Tytuł :
Intravenous administration of anakinra in children with macrophage activation syndrome.
Autorzy :
Phadke O; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA. .; Children's Healthcare of Atlanta, Atlanta, GA, USA. .
Rouster-Stevens K; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.; Children's Healthcare of Atlanta, Atlanta, GA, USA.
Giannopoulos H; Children's Healthcare of Atlanta, Atlanta, GA, USA.
Chandrakasan S; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.; Children's Healthcare of Atlanta, Atlanta, GA, USA.
Prahalad S; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.; Children's Healthcare of Atlanta, Atlanta, GA, USA.
Pokaż więcej
Źródło :
Pediatric rheumatology online journal [Pediatr Rheumatol Online J] 2021 Jun 29; Vol. 19 (1), pp. 98. Date of Electronic Publication: 2021 Jun 29.
Typ publikacji :
Journal Article
MeSH Terms :
Lupus Erythematosus, Systemic*/complications
Lupus Erythematosus, Systemic*/immunology
Lupus Erythematosus, Systemic*/therapy
Lymphohistiocytosis, Hemophagocytic*/complications
Lymphohistiocytosis, Hemophagocytic*/immunology
Lymphohistiocytosis, Hemophagocytic*/therapy
Macrophage Activation Syndrome*/blood
Macrophage Activation Syndrome*/drug therapy
Macrophage Activation Syndrome*/etiology
Administration, Intravenous/*methods
COVID-19/*drug therapy
Interleukin 1 Receptor Antagonist Protein/*administration & dosage
Systemic Inflammatory Response Syndrome/*drug therapy
Antirheumatic Agents/administration & dosage ; COVID-19/epidemiology ; COVID-19/immunology ; Child ; Child, Hospitalized/psychology ; Critical Illness/psychology ; Critical Illness/therapy ; Cytokine Release Syndrome/drug therapy ; Cytokine Release Syndrome/virology ; Female ; Humans ; Male ; Patient Comfort/methods ; Retrospective Studies ; SARS-CoV-2
SCR Disease Name :
pediatric multisystem inflammatory disease, COVID-19 related
Czasopismo naukowe
Tytuł :
Factors associated with treatment failure of direct-acting antivirals for chronic hepatitis C: A real-world nationwide hepatitis C virus registry programme in Taiwan.
Autorzy :
Chen CY; Division of Gastroenterology and Hepatology, Department of Medicine, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi, Taiwan.
Huang CF; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; School of Medicine and Hepatitis Research Center, College of Medicine, and Center for Cancer Research and Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Cheng PN; Division of Gastroenterology and Hepatology, Department of Internal Medicine, College of Medicine, National Cheng Kung University Hospital, National Cheng Kung University, Tainan, Taiwan.
Tseng KC; Department of Internal Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi, Taiwan.; School of Medicine, Tzuchi University, Hualien, Taiwan.
Lo CC; Division of Gastroenterology, Department of Internal Medicine, St. Martin De Porres Hospital, Chiayi, Taiwan.
Kuo HT; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan.
Huang YH; Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital.; Institute of Clinical Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan.
Tai CM; Department of Internal Medicine, E-Da Hospital, Kaohsiung, Taiwan.; School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan.
Peng CY; Center for Digestive Medicine, Department of Internal Medicine, School of Medicine, China Medical University Hospital, China Medical University, Taichung, Taiwan.
Bair MJ; Division of Gastroenterology, Department of Internal Medicine, Taitung Mackay Memorial Hospital, Taitung, Taiwan.; Mackay Medical College, New Taipei City, Taiwan.
Chen CH; Division of Hepato-Gastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Yeh ML; School of Medicine and Hepatitis Research Center, College of Medicine, and Center for Cancer Research and Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University, Kaohsiung, Taiwan.; Department of Internal Medicine, Kaohsiung Municipal Siaogang Hospital, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Lin CL; Department of Gastroenterology and Hepatology, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan.
Lin CY; Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Linkou Branch, Taoyuan, Taiwan.; Graduate Institute of Biomedical Science, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Lee PL; Liouying Division of Gastroenterology and Hepatology, Department of Internal medicine, Chi Mei Medical Center, Tainan, Taiwan.
Chong LW; Division of Hepatology and Gastroenterology, Department of Internal Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.; School of Medicine, Fu-Jen Catholic University, New Taipei City, Taiwan.
Hung CH; Division of Hepato-Gastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, College of Medicine, Chang Gung University, Taoyuan, Taiwan.; Division of Hepatogastroenterology, Department of Internal Medicine, ChiaYi Chang Gung Memorial Hospital, Puzi, Taiwan.
Huang JF; School of Medicine and Hepatitis Research Center, College of Medicine, and Center for Cancer Research and Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University, Kaohsiung, Taiwan.; Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Yang CC; Department of Gastroenterology, Division of Internal Medicine, Show Chwan Memorial Hospital, Changhua, Taiwan.
Hu JT; Liver Center, Cathay General Hospital, Taipei, Taiwan.
Lin CW; School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan.; Division of Gastroenterology and Hepatology, E-Da Dachang Hospital, Kaohsiung, Taiwan.
Chen CT; Division of Gastroenterology, Department of Internal Medicine, Tri-Service General Hospital Penghu Branch, National Defense Medical Center, Taipei, Taiwan.; Division of Gastroenterology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Wang CC; School of Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Tzu Chi University, Hualien, Taiwan.
Su WW; Department of Gastroenterology and Hepatology, Changhua Christian Hospital, Changhua, Taiwan.
Hsieh TY; Division of Gastroenterology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Lin CL; Department of Gastroenterology, Renai branch, Taipei City Hospital, Taipei, Taiwan.
Tsai WL; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
Lee TH; Division of Gastroenterology and Hepatology, Far Eastern Memorial Hospital, New Taipei City, Taiwan.
Chen GY; Penghu Hospital, Ministry of Health and Welfare, Taipei, Taiwan.
Wang SJ; Division of Gastroenterology, Department of Internal Medicine, Yuan's General Hospital, Kaohsiung, Taiwan.
Chang CC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan.; Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Mo LR; Division of Gastroenterology, Tainan Municipal Hospital, Tainan, Taiwan.
Yang SS; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
Wu WC; Wu Wen-Chih Clinic, Kaohsiung, Taiwan.
Huang CS; Yang Ming Hospital, Chiayi, Taiwan.
Hsiung CK; Chou Kwok Hsiung Clinic, Penghu, Taiwan.
Kao CN; National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan.
Tsai PC; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Liu CH; Hepatitis Research Center and Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Lee MH; Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Liu CJ; Hepatitis Research Center and Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Dai CY; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; School of Medicine and Hepatitis Research Center, College of Medicine, and Center for Cancer Research and Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Kao JH; Hepatitis Research Center and Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Chuang WL; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; School of Medicine and Hepatitis Research Center, College of Medicine, and Center for Cancer Research and Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Lin HC; Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital.; Institute of Clinical Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan.
Yu ML; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; School of Medicine and Hepatitis Research Center, College of Medicine, and Center for Cancer Research and Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Pokaż więcej
Źródło :
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2021 Jun; Vol. 41 (6), pp. 1265-1277. Date of Electronic Publication: 2021 Mar 12.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/epidemiology
Hepatitis C*/drug therapy
Hepatitis C, Chronic*/drug therapy
Liver Neoplasms*/drug therapy
Antiviral Agents/therapeutic use ; Drug Therapy, Combination ; Female ; Hepacivirus/genetics ; Humans ; Middle Aged ; Registries ; Sofosbuvir/therapeutic use ; Sustained Virologic Response ; Taiwan/epidemiology ; Treatment Failure ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Efficacy and tolerability of adjuvant perampanel: an Australian multicenter real-world observational study in refractory focal and generalized epilepsy syndromes.
Autorzy :
Sagar P; Department of Medicine, St Vincent's Hospital Melbourne, The University of Melbourne, Australia. Electronic address: .
Wawryk O; Department of Medicine, St Vincent's Hospital Melbourne, The University of Melbourne, Australia.
Vogrin S; Department of Medicine, St Vincent's Hospital Melbourne, The University of Melbourne, Australia.
Whitham E; Department of Neurology, Flinders Medical Centre, Australia.
Kiley M; Department of Neurology, Royal Adelaide Hospital, Australia.
Frasca J; Department of Neurology, Flinders Medical Centre, Australia.
Carne R; Department of Medicine, St Vincent's Hospital Melbourne, The University of Melbourne, Australia.
Seneviratne U; Department of Medicine, St Vincent's Hospital Melbourne, The University of Melbourne, Australia; Department of Neurology, Monash Medical Centre, Melbourne, Australia.
Cook MJ; Department of Medicine, St Vincent's Hospital Melbourne, The University of Melbourne, Australia.
Lawn N; Western Australian Adult Epilepsy Service, Sir Charles Gairdner Hospital, Perth, Australia.
Nikpour A; Department of Neurosciences, Royal Prince Alfred Hospital, Sydney, Australia; Sydney Medical School, University of Sydney, Australia.
D'Souza WJ; Department of Medicine, St Vincent's Hospital Melbourne, The University of Melbourne, Australia.
Pokaż więcej
Źródło :
Epilepsy & behavior : E&B [Epilepsy Behav] 2021 Jun; Vol. 119, pp. 107935. Date of Electronic Publication: 2021 Apr 27.
Typ publikacji :
Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Resistant Epilepsy*/drug therapy
Epilepsy, Generalized*/drug therapy
Epileptic Syndromes*/drug therapy
Adult ; Aged ; Anticonvulsants/therapeutic use ; Australia ; Drug Therapy, Combination ; Humans ; Male ; Pyridones/therapeutic use ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
A Cohort Study to Evaluate the Risk of Hospitalisation for Congestive Heart Failure Associated with the Use of Aclidinium and Other Chronic Obstructive Pulmonary Disease Medications in the UK Clinical Practice Research Datalink.
Autorzy :
Rebordosa C; RTI Health Solutions, Barcelona, Spain.
Plana E; RTI Health Solutions, Barcelona, Spain.
Rubino A; Epidemiology, Respiratory and Immunology, AstraZeneca, Cambridge, UK.
Aguado J; RTI Health Solutions, Barcelona, Spain.
Lei A; Patient Safety Biopharma, AstraZeneca, Barcelona, Spain.
Daoud S; BioPharmaceuticals Research and Development, Late-Stage Development Research and Innovation, AstraZeneca, Gaithersburg, MD, USA.
Saigi-Morgui N; RTI Health Solutions, Barcelona, Spain.
Perez-Gutthann S; RTI Health Solutions, Barcelona, Spain.
Rivero-Ferrer E; RTI Health Solutions, Barcelona, Spain.
Pokaż więcej
Źródło :
International journal of chronic obstructive pulmonary disease [Int J Chron Obstruct Pulmon Dis] 2021 May 31; Vol. 16, pp. 1461-1475. Date of Electronic Publication: 2021 May 31 (Print Publication: 2021).
Typ publikacji :
Journal Article
MeSH Terms :
Heart Failure*/chemically induced
Heart Failure*/diagnosis
Heart Failure*/drug therapy
Pulmonary Disease, Chronic Obstructive*/diagnosis
Pulmonary Disease, Chronic Obstructive*/drug therapy
Pulmonary Disease, Chronic Obstructive*/epidemiology
Administration, Inhalation ; Adrenal Cortex Hormones/therapeutic use ; Adrenergic beta-2 Receptor Agonists/adverse effects ; Adult ; Aged ; Bronchodilator Agents/adverse effects ; Cohort Studies ; Drug Therapy, Combination ; Europe/epidemiology ; Hospitalization ; Humans ; Muscarinic Antagonists/adverse effects ; United Kingdom/epidemiology
Czasopismo naukowe
Tytuł :
Challenges in Managing a Lepromatous Leprosy Patient Complicated with Melioidosis Infection, Dapsone-Induced Methemoglobinemia, Hemolytic Anemia, and Lepra Reaction.
Autorzy :
Tang ASO; Department of Internal Medicine, Miri General Hospital, Ministry of Health Malaysia, Miri, Sarawak, Malaysia.
Wong QY; Department of Internal Medicine, Miri General Hospital, Ministry of Health Malaysia, Miri, Sarawak, Malaysia.
Yeo ST; Department of Internal Medicine, Miri General Hospital, Ministry of Health Malaysia, Miri, Sarawak, Malaysia.
Ting IPL; Department of Internal Medicine, Miri General Hospital, Ministry of Health Malaysia, Miri, Sarawak, Malaysia.
Lee JTH; Department of Pathology, Sarawak General Hospital, Ministry of Health Malaysia, Kuching, Sarawak, Malaysia.
Fam TL; Department of Internal Medicine, Miri General Hospital, Ministry of Health Malaysia, Miri, Sarawak, Malaysia.
Chew LP; Haematology Unit, Department of Internal Medicine, Sarawak General Hospital, Sarawak, Ministry of Health Malaysia, Kuching, Sarawak, Malaysia.
Chua HH; Infectious Disease Unit, Department of Internal Medicine, Sarawak General Hospital, Ministry of Health Malaysia, Kuching, Sarawak, Malaysia.
Muniandy P; Dermatology Unit, Department of Internal Medicine, Sarawak General Hospital, Ministry of Health Malaysia, Kuching, Sarawak, Malaysia.
Pokaż więcej
Źródło :
The American journal of case reports [Am J Case Rep] 2021 May 26; Vol. 22, pp. e931655. Date of Electronic Publication: 2021 May 26.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Anemia, Hemolytic*/chemically induced
Anemia, Hemolytic*/drug therapy
Leprosy, Lepromatous*/complications
Leprosy, Lepromatous*/drug therapy
Melioidosis*
Methemoglobinemia*/chemically induced
Methemoglobinemia*/drug therapy
Adult ; Dapsone/adverse effects ; Drug Therapy, Combination ; Female ; Humans ; Leprostatic Agents/adverse effects ; Young Adult
Czasopismo naukowe
Tytuł :
Effectiveness of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C virus infection and virologic failure to direct-acting antivirals.
Autorzy :
Ruiz-Boy S; Servicio de Farmacia, Área del Medicamento, Hospital Clínic de Barcelona, Barcelona, España. Electronic address: .
Rodriguez-Reyes M; Servicio de Farmacia, Área del Medicamento, Hospital Clínic de Barcelona, Barcelona, España.
Sotoca-Momblona JM; Servicio de Farmacia, Área del Medicamento, Hospital Clínic de Barcelona, Barcelona, España.
Pokaż więcej
Transliterated Title :
Efectividad de sofosbuvir/velpatasvir/voxilaprevir en pacientes con infección crónica por el virus de la hepatitis C y fracaso virológico a otros antivirales de acción directa.
Źródło :
Medicina clinica [Med Clin (Barc)] 2021 Jul 23; Vol. 157 (2), pp. 85-86. Date of Electronic Publication: 2020 Aug 15.
Typ publikacji :
Case Reports; Letter
MeSH Terms :
Hepatitis C, Chronic*/drug therapy
Aminoisobutyric Acids ; Antiviral Agents/therapeutic use ; Carbamates ; Cyclopropanes ; Drug Combinations ; Drug Therapy, Combination ; Genotype ; Hepacivirus/genetics ; Heterocyclic Compounds, 4 or More Rings ; Humans ; Lactams, Macrocyclic ; Leucine/analogs & derivatives ; Proline/analogs & derivatives ; Quinoxalines ; Sofosbuvir/therapeutic use ; Sulfonamides
Raport
Tytuł :
Effect of gastric microbiota on quadruple Helicobacter pylori eradication therapy containing bismuth.
Autorzy :
Niu ZY; Department of Gastroenterology, Peking University Third Hospital, Beijing 100191, China.
Li SZ; Department of Gastroenterology, Peking University Third Hospital, Beijing 100191, China.
Shi YY; Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing 100191, China.
Xue Y; Department of Gastroenterology, Peking University Third Hospital, Beijing 100191, China. .
Pokaż więcej
Źródło :
World journal of gastroenterology [World J Gastroenterol] 2021 Jul 07; Vol. 27 (25), pp. 3913-3924.
Typ publikacji :
Journal Article
MeSH Terms :
Helicobacter Infections*/drug therapy
Helicobacter pylori*
Microbiota*
Amoxicillin/therapeutic use ; Anti-Bacterial Agents/therapeutic use ; Bismuth/therapeutic use ; Drug Therapy, Combination ; Humans ; Proton Pump Inhibitors/therapeutic use ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Evidence based guidelines for the treatment of Helicobacter pylori infection in Korea 2020.
Autorzy :
Jung HK; Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea.
Kang SJ; Department of Internal Medicine, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea.
Lee YC; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Yang HJ; Division of Gastroenterology, Department of Internal Medicine and Gastrointestinal Cancer Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Park SY; Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea.
Shin CM; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
Kim SE; Department of Internal Medicine, Kosin University College of Medicine, Busan, Korea.
Lim HC; Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea.
Kim JH; Department of Internal Medicine and Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea.
Nam SY; Center for Gastric Cancer, Kyungpook National University Chilgok Hospital, Daegu, Korea.
Shin WG; Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea.
Park JM; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Choi IJ; Center for Gastric Cancer, National Cancer Center, Goyang, Korea.
Kim JG; Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea.
Choi M; Division of Healthcare Technology Assessment Research, National Evidence-based Healthcare Collaborating Agency, Seoul, Korea.
Pokaż więcej
Corporate Authors :
Korean College of Helicobacter and Upper Gastrointesinal Research
Źródło :
The Korean journal of internal medicine [Korean J Intern Med] 2021 Jul; Vol. 36 (4), pp. 807-838. Date of Electronic Publication: 2021 Jun 08.
Typ publikacji :
Guideline; Meta-Analysis
MeSH Terms :
Helicobacter Infections*/diagnosis
Helicobacter Infections*/drug therapy
Helicobacter Infections*/epidemiology
Helicobacter pylori*
Amoxicillin/therapeutic use ; Anti-Bacterial Agents/therapeutic use ; Clarithromycin/therapeutic use ; Drug Therapy, Combination ; Humans ; Proton Pump Inhibitors/therapeutic use ; Randomized Controlled Trials as Topic ; Republic of Korea/epidemiology
Raport
Tytuł :
[Antipsychotic Polypharmacy in the Treatment of Patients with Schizophrenia in Nine Psychiatric Hospitals of the Landschaftsverband Rheinland, Germany].
Autorzy :
Schmidt-Kraepelin C; LVR-Klinikum Düsseldorf, Kliniken der Heinrich-Heine-Universität Düsseldorf.
Meisenzahl-Lechner E; LVR-Klinikum Düsseldorf, Kliniken der Heinrich-Heine-Universität Düsseldorf.; LVR-Institut für Versorgungsforschung, Köln.
Kujovic M; LVR-Klinikum Düsseldorf, Kliniken der Heinrich-Heine-Universität Düsseldorf.
Cordes J; LVR-Klinikum Düsseldorf, Kliniken der Heinrich-Heine-Universität Düsseldorf.; Kaiserswerther Diakonie, Florence-Nightingale-Krankenhaus, Düsseldorf.
Engelke C; LVR-Klinikum Düsseldorf, Kliniken der Heinrich-Heine-Universität Düsseldorf.
Riesbeck M; LVR-Klinikum Düsseldorf, Kliniken der Heinrich-Heine-Universität Düsseldorf.
Zielasek J; LVR-Institut für Versorgungsforschung, Köln.
Engemann S; LVR-Institut für Versorgungsforschung, Köln.
Vrinssen J; LVR-Institut für Versorgungsforschung, Köln.
Lehmann I; LVR-Institut für Versorgungsforschung, Köln.
Tönnesen-Schlack A; LVR-Klinik Bedburg-Hau.
Banger M; LVR-Klinik Bonn.
Grümmer M; LVR-Klinik Düren.
Scherbaum N; LVR-Klinikum Essen, Kliniken und Institut der Universität Duisburg-Essen.
Muysers J; LVR-Klinik Langenfeld.
Rinckens S; LVR-Klinik Mönchengladbach.
Marggraf R; LVR-Klinik Viersen.
Gouzoulis-Mayfrank E; LVR-Institut für Versorgungsforschung, Köln.; LVR-Klinik Köln.
Pokaż więcej
Transliterated Title :
Antipsychotische Polypharmazie in der Behandlung von Patientinnen und Patienten mit Schizophrenie am Beispiel von neun psychiatrischen Fachkliniken des Landschaftsverbandes Rheinland.
Źródło :
Psychiatrische Praxis [Psychiatr Prax] 2021 Jul; Vol. 48 (5), pp. 250-257. Date of Electronic Publication: 2021 Jan 20.
Typ publikacji :
Journal Article
MeSH Terms :
Antipsychotic Agents*/adverse effects
Schizophrenia*/drug therapy
Schizophrenia*/epidemiology
Drug Therapy, Combination ; Female ; Germany ; Hospitals, Psychiatric ; Humans ; Male ; Polypharmacy
Czasopismo naukowe
Tytuł :
Fixed-dose darunavir/cobicistat in pregnancy of HIV-infected women, pharmacokinetic concerns.
Autorzy :
Dash PK; Department of Pharmacology and Experimental Neuroscience, College of Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Boix V; Unit of Infectious Diseases, Hospital General Universitario de Alicante, ISABIAL, Alicante.; Departamento de Medicina Clínica, Universidad Miguel Hernandez, Elche, Spain.
Pokaż więcej
Źródło :
AIDS (London, England) [AIDS] 2021 Jul 01; Vol. 35 (8), pp. 1301-1303.
Typ publikacji :
Journal Article
MeSH Terms :
Anti-HIV Agents*/therapeutic use
HIV Infections*/drug therapy
HIV Protease Inhibitors*/therapeutic use
Cobicistat/therapeutic use ; Darunavir/therapeutic use ; Drug Therapy, Combination ; Female ; Humans ; Pregnancy
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies